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Abstract 
Purpose 
Vigabatrin (VGB) is an anti-epileptic medication which has been linked to peripheral 
constriction of the visual field. Documenting the natural history associated with continued 
VGB exposure is important when making decisions about the risk and benefits associated 
with the treatment. Due to its speed the Swedish Interactive Threshold Algorithm (SITA) has 
become the algorithm of choice when carrying out Full Threshold automated static perimetry. 
SITA uses prior distributions of normal and glaucomatous visual field behaviour to estimate 
threshold sensitivity. As the abnormal model is based on glaucomatous behaviour this 
algorithm has not been validated for VGB recipients. We aim to assess the clinical utility of 
the SITA algorithm for accurately mapping VGB attributed field loss. 
Methods 
The sample comprised one randomly selected eye of 16 patients diagnosed with epilepsy, 
exposed to VGB therapy. A clinical diagnosis of VGB attributed visual field loss was 
documented in 44% of the group. The mean age was 39.3 years ± 14.5 years and the mean 
deviation was -4.76 dB ±4.34 dB. Each patient was examined with the Full Threshold, SITA 
Standard and SITA Fast algorithm. 
Results 
SITA Standard was on average approximately twice as fast (7.6 minutes) and SITA Fast 
approximately 3 times as fast (4.7 minutes) as examinations completed using the Full 
Threshold algorithm (15.8 minutes). In the clinical environment, the visual field outcome 
with both SITA algorithms was equivalent to visual field examination using the Full 
Threshold algorithm in terms of visual inspection of the grey scale plots , defect area and 
defect severity. 
Conclusions 
Our research shows that both SITA algorithms are able to accurately map visual field loss 
attributed to VGB. As patients diagnosed with epilepsy are often vulnerable to fatigue, the 
time saving offered by SITA Fast means that this algorithm has a significant advantage for 
use with VGB recipients. 
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Background 
Vigabatrin (VGB) is the first purposely designed anti-epileptic medication. It is administered 
as a first line therapy to patients suffering from Infantile Spasms and as an adjunctive therapy 
to patients with complex partial seizures [1,2]. VGB was initially approved for use within the 
United Kingdom and several other European countries in 1989 however, it is now well 
established that VGB therapy can induce peripheral constriction of the visual field. Reports of 
the prevalence of this defect range between 17% [3] and 86% [4]. The risk of VGB attributed 
field loss appears to be lower in children less than 12 years old exposed to VGB when 
compared to adults and adolescents who receive VGB at a later age [5,6]. General consensus 
suggests that the visual field loss is permanent [7,8]. Positive relationships between the visual 
field loss and cumulative dosage [3,8-10] duration of vigabatrin therapy [6,8-11] and 
maximum daily dosage [12] have all been documented. Despite these known side effects, in 
the last few years VGB has become licensed in Canada, Mexico and the United States for the 
same uses as reported above. 
Patients receiving VGB are frequently monitored using either kinetic perimetry or automated 
static perimetry [13]. Vigabatrin attributed visual field loss is two and a half times more 
common with automated static perimetry when compared to manual kinetic perimetry [14]. 
The authors attributed these findings to the fact that in general, static perimetry is more 
sensitive than kinetic perimetry for the detection of field loss [15]. Static perimetry is 
normally carried out using the Swedish Interactive Threshold Algorithms (SITA). These 
algorithms were developed with the specific aim of offering a significant reduction in 
examination time but without sacrificing any loss in the accuracy of threshold estimation 
when compared to the Full Threshold and FASTPAC algorithms [16,17]. 
SITA is based on prior distributions of normal and abnormal visual field behaviour to 
estimate the threshold. The prior distribution models contain information on age-corrected 
normal threshold values, frequency-of-seeing curves, between-subject variability and inter-
point correlations between thresholds [16]. The abnormal visual field model is based on a 
glaucomatous population and thus inter-point correlations of threshold values would be based 
upon the retinal nerve fibre arrangement [18]. VGB induced visual field loss however is 
thought to result from a toxic effect in the retina and as such may not precisely conform to the 
nerve fibre bundle. Consequently, SITA may map a response for VGB recipients which are 
artificially influenced by the glaucomatous model. 
To date, the only study to have examined whether SITA was valid in patients with non-
glaucomatous pathologies, such as optic neuropathies and hemianopias, reported that SITA 
Standard was at least as good as Full Threshold for the detection of visual loss in individual 
examinations [19]. For VGB recipients it is essential that we accurately document the natural 
progression associated with continued VGB exposure. This information is vital when making 
decisions on management as it allows the patient and practitioner an opportunity to weigh up 
the risks and benefits associated with continued treatment. 
The aim of this investigation was to assess the clinical utility of the SITA algorithms for the 
investigation of patients receiving VGB. Firstly, by determining the threshold agreement 
between the different algorithms. Secondly, by determining the threshold agreement within 
the same algorithm across two successive visits. Thirdly, the agreement of the diagnostic 
outcome was assessed in terms of area and depth of defect. 
Methods 
Twenty-Two participants: 12 females and 10 males (mean age 38.54 years, SD 13.45, range 
16 to 61 years) who were undergoing or who had previously undergone treatment with VGB 
were invited to take part in the study. Four participants were removed from the study as they 
had a visual field defect not attributed to VGB another two participants were removed 
because of poor reliability. The sample therefore consisted of 16 epilepsy patients; 10 females 
and 6 males (mean age 39.3, SD 14.52, range 18 to 61). Patients were recruited from National 
Health Service hospitals in the United Kingdom and written informed consent was obtained 
from each participant prior to commencement of the study. Approval for the study was given 
by the Aston University Human Sciences Ethical Committee and adhered to the tenets of the 
Declaration of Helsinki. 
Vigabatrin recipients had their visual field measured using both SITA strategies and the Full 
Threshold algorithm. The Full Threshold algorithm does not use prior distributions of normal 
and abnormal visual field behaviour to estimate threshold sensitivity but instead employs a 4-
2 dB staircase to estimate each threshold sensitivity. The design of the Full Threshold 
algorithm ensures that the visual field is not artificially influenced by prior models and 
therefore provided the gold standard for mapping VGB attributed field loss. At the first visit, 
all patients underwent a 30-2 visual field examination on both eyes using the Full Threshold 
algorithm (Humphrey Field Analyser 750 software version A10.2). This visit served to 
reduce the learning effect observed in perimetry [20] and the results were not used for data 
analysis. At the second and third visits, each patient underwent perimetry on one randomly 
assigned eye which remained constant for a given patient according to one of four randomly 
assigned protocols (Table 1). This unconventional order protocol was designed to induce 
similar degrees of fatigue within all three algorithms by ensuring that the first and second test 
sessions were of similar duration. 
Table 1 The test order sequence randomly assigned to patients 
Protocol Test order sequence for visit 2 and visit 3   
 First Session Rest period Second Session 
A Full Threshold 30 minute rest 
period 
SITA Standard then SITA Fast 
B Full Threshold 30 minute rest 
period 
SITA Fast then SITA Standard 
C SITA Standard then SITA Fast 30 minute rest 
period 
Full Threshold 
D SITA Fast then SITA Standard 30 minute rest 
period 
Full Threshold 
Visual fields obtained from the left eye were changed to the right eye format and the stimulus 
locations immediately above and below the blind spot were removed from the analysis which 
was twofold. Firstly, threshold data was evaluated in terms of threshold agreement between 
algorithms (during visit 3) and threshold agreement within algorithm (between visit 2 and 3). 
The second analysis was in terms of the clinical status of the visual field both within and 
between threshold algorithms. 
Results 
The sample comprised a typical cross section of VGB therapy patients (Table 2). Forty four 
percent of the patients had a confirmed clinical diagnosis of VGB attributed field loss from 
their medical records. The diagnosis was made independently from the research study for 
purely clinical purposes. Visual field defects exhibited a bilateral symmetrical defect showing 
concentric constriction of the peripheral visual field which was more pronounced nasally and 
typically characteristic of VGB attributed field loss. The other 66% of the sample had a 
confirmed clinical diagnosis of no visual field loss from their medical records. All patients 
had a visual acuity of 6/9 or better and ametropia not exceeding ±5.00 day and ±2.50 day of 
astigmatism. No patient had a history of ocular disease or previous surgery to their eye or 
brain. All visual fields fell inside the criteria of less than 33% false positive, less than or 
equal to 33% false negative and 20% fixation losses (see Additional file 1: Table S1). We 
acknowledge that the false negative rate was higher for the patients with significant visual 
field loss. However, it is now well recognised in perimetry that the false negative catch trial 
methods are not suitable for estimating patient attentiveness in eyes with significant visual 
field loss visual field loss as the frequency of false-negative responses in eyes with visual 
field defects is associated with amount of field loss [21]. 
Table 2 The epileptic medications of the patient group concomitant with vigabatrin and the seizure history 
Patient 
number 
Seizure history Carbamazepine Sodium 
Valporate 
Clobazam Levetiracetam Topiramate Lamotrogine Phenytoin Gabapentin Other 
1 Unknown       X  X 
2 generalised X X X   X  X X 
3 Complex partial partial/secondary 
generalised 
     X   X 
4 Complex partial          
5 Simple/complex  X  X      
6 Complex partial X       X  
7 Complex partial X   X      
8 Unknown X    X     
9 Generalised      X    
10 Complex partial X   X      
11 Complex partial   X   X    
12 Unknown X         
13 Generalised X X    X X  X 
14 Complex partial partial/secondary 
generalised 
   X      
15 Unknown X X     X   
16 Complex partial partial/secondary 
generalised 
  X   X  X  
Threshold agreement between and within algorithms 
One-way analysis of variance (between-subject) was used to determine whether there was 
any significant difference between examination duration, mean sensitivity (MS) mean 
deviation (MD) and pattern standard deviation (PSD), in any of the three algorithms resulting 
from the various sequence options of perimetric examination. There was no significant 
difference between protocol and visual field index at the third visit indicating that the 
unconventional order protocol did not influence threshold sensitivities. The group mean 
values for MS, MD, PSD and test duration (±1 SD) for each algorithm at the second and third 
visits are illustrated in Table 3. 
Table 3 Group global indices and examination times 
 Full Threshold SITA Standard SITA Fast 
Mean Sensitivity (dB) Visit 2 24.30 (5.28) 25.30 (5.66) 26.14 (5.36) 
Visit 3 24.05 (5.04) 25.30 (6.29) 25.56 (5.34) 
Mean Deviation (dB) Visit 2 −4.24 (4.00) −4.25 (4.46) −3.90 (4.76) 
Visit 3 −4.89 (3.79) −5.06 (4.98) −4.34 (4.25) 
Pattern Standard Deviation (dB) Visit 2 4.70 (3.67) 4.78 (3.91) 3.99 (3.30) 
Visit 3 4.89 (3.51) 4.95 (3.97) 4.63 (3.64) 
Examination Time (seconds) Visit 2 937.0 (157.9) 449.0 (80.9) 279.4 (79.2) 
Visit 3 956.6 (165.1) 464.1 (99.4) 282.3 (67.3) 
For MD and PSD, there was no difference between algorithms or visit order. The mean 
sensitivity of SITA Standard was 1.25 dB higher and 1.51 dB higher for the SITA Fast 
algorithm at the final visit compared to the Full Threshold algorithm SITA Standard (7 .6 
minutes) and SITA Fast (4.7 minutes) were significantly faster than Full Threshold perimetry 
(15.8 minutes). 
The threshold agreement within each algorithm across 2 successive visits was assessed by 
calculating the root mean square error (RMSE) for all test locations, participants and 
algorithms. The visual field was sectorised into outer, middle and inner zones of eccentricity; 
the outer zone comprised of 24 points from 25.8 to 28.5 degrees from fixation, the middle 
zone comprised 20 stimulus locations from 21.2 to 22.8 degrees from fixation and the inner 
zone comprised of 30 stimulus locations from 4.2 to 17.5 degrees from fixation (Figure 1). 
Figure 2 shows the 95% confidence intervals for the RMSE as a function of threshold 
algorithm for the whole field and the outer, middle and inner visual field regions. Within 
algorithm threshold variability was lowest in the inner ring for all threshold algorithms. As 
sectors increase in eccentricity from fixation, the group mean RMSE increased indicating less 
threshold agreement within an algorithm across visits 2 and 3. Both SITA algorithms had less 
threshold agreement (group mean RMSE) and larger confidence intervals across all visual 
field regions when compared to Full Threshold (Figure 2). Within the outer field region the 
RMSE with SITA Fast was 27% higher than Full Threshold and SITA Standard was 19% 
higher than Full Threshold (p =0.017). Similar differences were found across all field regions. 
Figure 1 Illustration of outer (black), middle (grey) and inner (white) sectors (blind spot 
dashed lines). 
Figure 2 Root Mean Square Error (dB) and 95% Confidence Intervals as a function of 
algorithm for the whole field, outer ring, middle ring and inner ring. 
Clinical status of the visual field 
All visual fields were categorised using the classification defined by Wild et al (2009) [22]. 
Visual defects ranged from mild to severe (Table 4) based on the number and position of 
stimulus locations exhibiting an abnormality at either p < 0.01 or p < 0.005 out to 30 degrees 
eccentricity for static threshold perimetry and were present in 38% after Full threshold was 
assigned the gold standard for the detection of VGB attributed visual field loss. The false 
positive and false negative rate was then calculated for both SITA algorithms. False positive 
rate was defined as the proportion of persons falsely identified as diseased persons by SITA 
Standard or SITA Fast in those without any VGB attributed field loss identified by the gold 
standard Full Threshold algorithm. One patient was falsely diagnosed as having VGB 
attributed visual field loss with both SITA algorithms when there was none documented on 
Full Threshold (1/10 = 10%) suggesting that the false positive rate was 10% for both SITA 
algorithms. Closer inspection of the “normal” Full Threshold visual field plot (patient 15 
Figure 3) reveals that if those locations demonstrating a 2% loss on pattern probability 
analysis were also included in the analysis then the patient would have been diagnosed with a 
VGB attributed defect. Additionally, information from their medical records shows that this 
patient had a confirmed clinical diagnosis of a VGB attributed field loss from previous visual 
field testing. The false negative rate was defined as the proportion of persons falsely 
identified as normal by SITA Standard or SITA Fast, among people with VGB attributed 
field loss identified by the gold standard Full Threshold algorithm. SITA standard correctly 
identified all patients with VGB attributed field loss documented on Full Threshold as having 
VGB attributed field loss on SITA standard suggesting a false negative rate of 0%. One 
patient was falsely identified as being normal with SITA Fast when there was a VGB 
attributed defect on the Full Threshold algorithm (1/6) suggesting a false negative rate of 
17%. Closer inspection of the falsely identified field reveals that if those locations 
demonstrating a 2% loss on shape probability analysis were also included in the analysis then 
the patient would have been correctly diagnosed. 
Table 4 Severity classification for all patients categorised using criteria by Wild et al 
(2009) [19] 
Patient no. Full Threshold SITA Standard SITA Fast 
 Classification Classification Classification 
1 Severe Severe Severe 
2 Moderate Moderate Moderate 
3 Nil Nil Nil 
4 Nil Nil Nil 
5 Moderate Moderate Moderate 
6 Nil Nil Nil 
7 Mild Mild Nil 
8 Nil Nil Nil 
9 Nil Nil Nil 
10 Nil Nil Nil 
11 Severe Severe Severe 
12 Nil Nil Nil 
13 Nil Nil Nil 
14 Severe Severe Severe 
15 Nil Severe Moderate 
16 Nil Nil Nil 
Figure 3 Grey Scale plots for all patients with a VGB attributed visual field defect: left 
Full Threshold, middle SITA Standard, right SITA Fast. 
To further assess the similarity in area of any visual field defect mapped by each threshold 
algorithm the number of non-overlapping defects or normal locations between two visual 
fields i.e. the dissimilarity between the fields was calculated and expressed as a percentage of 
the total number of visual field locations. Comparisons were made between threshold 
algorithms at visit 3 and also within each algorithm between visits 2 and 3. The group mean 
differences are illustrated in Table 5. 
Table 5 Group mean percentage of dissimilar total probability stimulus locations 
classified as normal or defective (±1 SD) threshold algorithms at the final visit (top) and 
between examinations using the same threshold algorithm (bottom) 
 Percentage Difference in Defect Area Between Threshold Algorithm 
(at Visit 3) 
Full Threshold - SITA 
Standard 
Full Threshold - SITA 
Fast 
SITA Standard - SITA 
Fast 
Total 
Deviation 
16.2 (16.8) 17.1 (17.9) 17.1 (17.5) 
 Percentage Difference in Defect Area Within Threshold Algorithm 
(between Visits 2 and 3) 
Full Threshold SITA Standard SITA Fast 
Total 
Deviation 
14.0 (14.2) 13.0 (13.3) 19.6 (20.5) 
For total deviation probabilities, the average area of visual field defect between two threshold 
algorithms at the final visit varied by up to 17%. Although the least variation was 
demonstrated between Full Threshold and SITA Standard none of the differences were found 
to be statistically significant. Using a given threshold algorithm the average area of visual 
field defect varied by a maximum of 20% of stimulus locations between the second and third 
visits. Although SITA Fast yielded the greatest difference there was no statistical difference 
in this variability between threshold algorithms. 
In order to demonstrate how each SITA algorithm displays the spatial pattern of VGB 
attributed field loss. The grey scale plots from all 3 testing strategies are presented for every 
patient with confirmed VGB attributed field loss (Figure 3) and also those without visual 
field loss (Additional file 2: Figure S1). Visual field plots were generated from the Humphrey 
sensitivity values (dB) using software which is freely available from one of the authors (HZ) 
[23,24]. Visual inspection of the plots shows they were approximately equivalent, for all 3 
algorithms, for every patient with and without a confirmed VGB attributed visual field defect. 
In order to analyse differences between algorithms in estimating defect depth, each stimulus 
location was given a numerical value corresponding to the level of total or pattern deviation 
significance (0 = not significant, 1 = 5%, 2 = 2%, 3 = 1%, 4 = 0.5%). For every patient the 
sum of all visual field locations was calculated for each algorithm for both total and pattern 
deviation probability plots (Figure 4). A repeated measures analysis of variance was 
conducted to explore any differences in estimating defect depth across all three algorithms for 
either total or pattern deviation probability plots. As you can see from Figure 4 overall the 
SITA Standard algorithm produced the most severe visual field loss, for each patient 
followed by SITA Fast and Full Threshold. These small differences however did not reach 
statistical significance between algorithms for either total deviation or the pattern deviation 
probability plots. 
Figure 4 Showing the sum of total deviation aggregate (Top) and pattern deviation 
aggregate (bottom) probability levels for every patient. 
Discussion 
The findings that both SITA Standard was on average approximately twice as fast (7.6 
minutes) and SITA Fast approximately 3 times as fast (4.7 minutes) as examinations 
completed using the Full Threshold algorithm (15.8 minutes) is in agreement with other 
studies of SITA in the normal population [25,26] in the investigation of glaucoma [27] and 
neuro-ophthalmological conditions [19] and adds nothing new to the existing literature. Test 
duration is of particular importance when examining patients with epilepsy as they are more 
prone to fatigue than other patient groups [28]. Researchers have shown that approximately 
25% of patients (n = 734) with epilepsy are unable to produce a conclusive visual field test at 
any visit [14]. This finding suggests that examination speed is particularly important in this 
group of patients and has led the authors to suggest that ocular imaging of the retinal nerve 
fibre layer [29,30] might be a useful technique for those patients who are unable to carry out 
perimetry. Based on examination times our results suggest that SITA Fast would be the 
obvious choice of algorithm however it is vital that the algorithm of choice is able to yield 
both a high threshold agreement and a comparable diagnostic outcome equivalent to the Full 
Threshold algorithm. 
Compared to the Full Threshold algorithm, the group mean pointwise sensitivities were on 
average 1.1 dB greater for SITA Standard and 1.7 dB greater for SITA Fast (Table 3). These 
results are concordant with findings in both normal and glaucomatous populations which 
report higher sensitivity as a function of algorithm in the order Full Threshold < SITA 
Standard < SITA Fast [31]. The higher sensitivity of SITA compared to the Full Threshold 
algorithm would be expected in SITA as the threshold is defined as the stimulus intensity 
which has a probability of seeing of 50% whereas in Full Threshold the estimate is the last 
seen stimulus using a step size of 2 dB [32]. Differences between SITA types could be 
explained by the greater imprecision in threshold estimate of SITA Fast which is integral to 
the design of the algorithm [16]. 
When considering the global indices MD and PSD there was no significant difference 
between any of the algorithms which suggests that they are interchangeable as diagnostic 
algorithms. However, global measures of the visual field status do not give a true 
representation of the nature and depth of visual field loss and do not yield any spatial 
information relating to the extent of visual field loss. Thus, it is necessary to examine the 
pointwise differences in sensitivity between and within threshold algorithms. 
Threshold agreement within and between algorithms when defined by the RMSE was 
assessed for the whole visual field and in the concentric outer, middle and inner rings (Figure 
1). Each algorithm yielded the smallest group RMSE within the inner rings and the greatest 
RMSE for the outer ring. This finding is unsurprising as the inner visual field ring is 
relatively spared by VGB toxicity and predominantly yields thresholds which are considered 
within the normal range. Furthermore, normal threshold variability increases with eccentricity 
which is reflected in greater confidence intervals in the visual field periphery [18]. As the 
frequency of defect in VGB toxicity is greatest in the outer ring [12], the magnitude of the 
RMSE is also greater because this visual field area is damaged and thus contains a wider 
range of threshold values. Both SITA algorithms had less threshold agreement (group mean 
RMSE) and larger confidence intervals across all visual field regions when compared against 
Full Threshold (Figure 2). Within the outer field region the RMSE with SITA Fast was 27% 
higher than Full Threshold and SITA Standard was 19% higher than Full Threshold. Similar 
differences were found across all field regions suggesting that the SITA algorithms are 
equivalent methods for quantifying VGB attributed field loss. Visual fields are often 
unreliable in patients diagnosed with epilepsy [6]. When evaluating serial visual field tests 
researchers have reported that VGB recipients often show a variable degree of “normal” 
fluctuation that is not related to the pathological damage itself [33]. Both SITA algorithms 
demonstrated slightly less threshold agreement and larger between-subject variability when 
compared against the Full threshold algorithm (Figure 2). This might be because the faster 
paced SITA algorithms might be slightly more difficult in patients diagnosed with epilepsy 
either because of the aetiology associated with the epilepsy itself or because of the 
combination of medications that they are receiving. 
Diagnostic outcome agreement was assessed in terms of false positive and false negative rate, 
area of defect, grey scale plots and depth of the defect. Results have indicated that the false 
negative rate was 0% for SITA Standard and 17% for SITA Fast. Closer inspection of the one 
falsely identified field reveals that if those locations which demonstrated a 2% loss on shape 
probability analysis were also included in the analysis then the patient would also have been 
correctly diagnosed as having VGB attributed field loss using SITA Fast. The false positive 
rate of both SITA strategies was 10% (n = 1). Further inspection of the “normal” visual field 
documented with Full Threshold algorithm however suggests a borderline visual field defect 
suggestive of VGB toxicity. Additionally, information from the patient’s medical records 
confirmed a clinical diagnosis of a VGB attributed field loss on previous visual field testing. 
This finding suggests that both SITA were correct in their diagnosis of a VGB attributed 
defect and the false positive rate was therefore 0%. 
On average, in terms of defect area there was a lack of coincidence of the defect at 
approximately 17% of stimulus locations (total deviation probability). This inconsistency 
may reflect the normal physiological and psychological factors which influence perimetric 
examination [20,34]. When one threshold algorithm was compared to another, the level of 
probability defining the defect depth showed little difference across all algorithms. Whilst 
SITA Standard gave comparable results to the Full Threshold algorithm in terms of the defect 
depth at successive examinations, SITA Fast showed slightly less agreement. However, this 
difference was small and there was no statistical difference in this variability between 
threshold algorithms consequently this factor is not expected to confound clinical diagnosis. 
Results are in agreement with a visual inspection of the grey scale plots which reveals that all 
3 algorithms produce equivalent field loss in relation to their grey scale plots (Figure 3). 
Overall SITA Standard algorithm appeared to show the greatest severity of visual field loss, 
for each patient followed by SITA Fast and Full Threshold (Figure 5). These small 
differences however again did not reach statistical significance between algorithms for either 
total deviation or the pattern deviation probability plots. 
Our research was able to detect differences between algorithms on both a global and regional 
level suggesting that the sample size was large enough to detect these subtle differences. 
However like most studies we acknowledge that our study would probably benefit from 
replication. We have demonstrated that the SITA threshold modelling procedure is capable of 
mapping the nature of VGB induced visual field loss in terms of its area and depth. In the 
ideal clinical environment the optimal threshold algorithm used in perimetry should be fast 
but able to accurately estimate the threshold consistently across successive examinations. 
Until the arrival of SITA there was always a trade off between reducing speed of examination 
and increasing variability in the threshold which had implications for both initial diagnosis 
and monitoring of visual field loss over time. 
In the clinical environment, the visual field outcome with both SITA algorithms was directly 
equivalent to visual field examination using the Full Threshold algorithm in terms of defect 
area, defect severity and visual inspection of the grey scale plot. SITA was not comparable 
when threshold agreement within each algorithm (RMSE) was calculated between Full 
Threshold and the SITA algorithms for the outer ring (p = 0.017). When we analyzed how 
these small differences in threshold agreement transferred into the number of non-
overlapping defects or normal locations between two visual fields within the same algorithm. 
We found little variation suggesting that these differences have little clinical impact. 
The only other study to have evaluated SITA’s efficacy in detecting eye disease other than 
glaucoma concluded that SITA Standard was at least as good as the Full Threshold in 
detecting both optic neuropathy and hemianopic visual field loss [19]. The authors were 
unable to comment on SITA’s efficacy in examining these pathologies across visits as they 
did not carry out serial visual field tests. 
Conclusion 
Our research shows that both SITA algorithms are able to accurately map visual loss 
attributed to VGB across 2 successive examinations. Our findings in conjunction with the 
knowledge that patients diagnosed with epilepsy are particularly vulnerable to fatigue [28] 
suggest that SITA Fast might have an advantage when testing this particular group of 
patients. 
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